Furthermore, TMEM16A blockers niflumic acid and benzbromarone, prevented hyperresponsiveness in vivo and in vitro in an ovalbumin-induced asthma model in C57BL/6 mice (Zhang et al., 2013). This evidence concerns the gene ANO1 and asthma.